Loading company…
Smartlens develops contact lens-based devices that monitor intraocular pressure for people with glaucoma.
Founded in 2015 and based in Sunnyvale, US, Smartlens develops miLens, a daily contact lens device for measuring intraocular pressure and helping patients manage glaucoma. It is designed to provide microdose personalized treatments based on diurnal pressure and works with glaucoma medications. In October 2025, the company raised USD 5.2 million in venture funding led by Ambit Health Ventures, with Graphene Ventures, Boutique Venture Partners, Harvard Business School Alumni Angels, and other investors participating. The funding is intended to support FDA clearance and preparation for launch.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in